Application prospects of urine-derived stem cells in neurological and musculoskeletal diseases

doi:10.5312/wjo.v15.i10.918

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1224)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

HTML

752

Figures (1-2)

Tables (1-3)

132

Sum=975

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

101

Sum=168

Publishing Process of This Article

Item

Count

Browse

Download

Sum=52

Oct 18, 2024 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Orthop. Oct 18, 2024; 15(10): 918-931
Published online Oct 18, 2024. doi: 10.5312/wjo.v15.i10.918

Table 2 Reprogramming methods of urine-derived stem cells

Reprogramming method	Vectors	Factors	Ref.
SeV	SeV	OSKM	[15,43,44,48,49,58,60,63,71]
		OCT4, SOX2, NANOG, LIN28
		JDP2, JHDM1B, MKK6, GLIS1, NANOG, ESSRB, SALL4
Exogenous plasmids	Epi	KLD4, MYC, OCT4, SOX2, LIN28, shP53
		OCT4, SOX2, KLF4, miR-302-367
		OCT4, SOX2, NANOG, LIN28, KLF4 and MYC	[85,86]
		OCT4, SOX2, SV40 LT, KLF4 and miR302-367
		OCT4, SOX2, NANOG, MYC, KLF4, LIN28
		OCT4, SOX2, KLF4, and miR-302-367
	pCXLE-hOCT4-shP53-F, pCXLE-hSK, pCXLE-h UL	OSKM, shP53, LIN28
	TET-ON-induced expression vector	OSKM
	pEP4EO2SET2K	OCT4, SOX2, SV40 LT and KLF4, miR-302b, c, a, d and miR-367
SM		Cyclic pifithrin-a, A-83-01, CHIR99021, thiazovivin, NaB, PD0325901
mRNA		OSKM LNg
srRNA		OSKM, NSP 1-4
Lentivirus	Lentiviral vectors	OSKM

ESSRB: Estrogen related receptor beta; Epi: Episomal vector; JHDM1B: Jumonji C domain-containing histone demethylase 1B; KLD4: Kelch domain-containing protein 4miR: MicroRNA; MKK6: Mitogen-activated protein kinase kinase 6; NaB: Sodium butyrate; NSP: Non-structural proteins; OSKM: Octamer-binding transcription factor 4, sex determining region Y-box transcription factor 2, kruppel-like factor 4, and myelocytomatosis oncogene; SeV: Sendai virus; shP53: P53 short-hairpin RNA; SM: Small molecules; srRNA: Self-replicating mRNA; SV40 LT: Simian virus 40 large T antigen.

Citation: Yang HS, Zheng YX, Bai X, He XY, Wang TH. Application prospects of urine-derived stem cells in neurological and musculoskeletal diseases. World J Orthop 2024; 15(10): 918-931
URL: https://www.wjgnet.com/2218-5836/full/v15/i10/918.htm
DOI: https://dx.doi.org/10.5312/wjo.v15.i10.918